CERS Cerus Corporation Stock Quote

CERS [NASD]

Index	-	P/E	-	EPS (ttm)	-0.35	Insider Own	1.50%	Shs Outstand	171.90M	Perf Week	-3.23%
Market Cap	1.18B	Forward P/E	-	EPS next Y	-0.29	Insider Trans	-14.84%	Shs Float	167.70M	Perf Month	4.39%
Income	-59.60M	PEG	-	EPS next Q	-0.08	Inst Own	83.10%	Short Float	5.58%	Perf Quarter	6.82%
Sales	143.00M	P/S	8.27	EPS this Y	28.30%	Inst Trans	-0.33%	Short Ratio	8.46	Perf Half Y	22.60%
Book/sh	0.47	P/B	14.66	EPS next Y	8.30%	ROA	-27.00%	Target Price	10.20	Perf Year	3.61%
Cash/sh	0.70	P/C	9.85	EPS next 5Y	-	ROE	-66.10%	52W Range	4.67 - 8.87	Perf YTD	-0.43%
Dividend	-	P/FCF	-	EPS past 5Y	8.90%	ROI	-38.60%	52W High	-22.77%	Beta	1.16
Dividend %	-	Quick Ratio	2.30	Sales past 5Y	27.30%	Gross Margin	60.70%	52W Low	46.68%	ATR	0.26
Employees	270	Current Ratio	2.80	Sales Q/Q	44.20%	Oper. Margin	-39.30%	RSI (14)	45.04	Volatility	3.77% 4.00%
Optionable	Yes	Debt/Eq	0.81	EPS Q/Q	14.80%	Profit Margin	-41.70%	Rel Volume	0.62	Prev Close	6.89
Shortable	Yes	LT Debt/Eq	0.68	Earnings	Nov 02 AMC	Payout	-	Avg Volume	1.11M	Price	6.85
Recom	1.40	SMA20	-5.99%	SMA50	2.65%	SMA200	12.09%	Volume	383,372	Change	-0.58%

Oct-08-20

Resumed

BTIG Research

Buy

Jun-16-20

Resumed

Cantor Fitzgerald

Overweight

Feb-26-20

Initiated

BTIG Research

Buy

Nov-13-19

Upgrade

BTIG Research

Neutral → Buy

Aug-28-19

Initiated

Stifel

Buy

Aug-23-19

Resumed

Stephens

Overweight

Jan-05-18

Resumed

Cantor Fitzgerald

Overweight

Dec-08-17

Resumed

BTIG Research

Neutral

Jul-07-16

Resumed

Cantor Fitzgerald

Buy

Dec-17-15

Downgrade

Wedbush

Outperform → Neutral

May-02-14

Reiterated

MLV & Co

Buy

$8.50 → $6

Apr-24-13

Reiterated

Cantor Fitzgerald

Buy

$5.50 → $6

Mar-15-13

Reiterated

MLV & Co

Buy

$7.50 → $8.50

Apr-17-12

Initiated

Cantor Fitzgerald

Buy

$5.50

Feb-29-12

Upgrade

Robert W. Baird

Neutral → Outperform

$3 → $6

Nov-10-11

Reiterated

MLV & Co

Buy

$4 → $5

Jun-03-11

Initiated

Wedbush

Outperform

Mar-04-11

Downgrade

Robert W. Baird

Outperform → Neutral

$4 → $3

Mar-09-10

Upgrade

Robert W. Baird

Neutral → Outperform

$3 → $5

Aug-26-09

Upgrade

Avondale

Mkt Perform → Mkt Outperform

$2 → $5

Nov-24-21 10:00AM	Wall Street Analysts Think Cerus (CERS) Could Surge 35%: Read This Before Placing a Bet Zacks
Nov-19-21 08:00AM	Cerus Corporation to Participate in Stephens Annual Investment Conference Business Wire
Nov-10-21 11:43AM	Notable Cerus Insider Trades $1.3M In Company Stock Benzinga
Nov-08-21 10:06AM	Chief Medical Officer Of Cerus Trades $2M In Company Stock Benzinga
08:00AM	Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference Business Wire
Nov-03-21 12:03PM	54 Stocks Moving In Wednesday's Mid-Day Session Benzinga +16.59%
08:04AM	Cerus Posts Lower Than Expected Q3 Loss; Raises FY21 Sales Guidance Benzinga
05:01AM	Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript Motley Fool
Nov-02-21 05:25PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:00PM	Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance Business Wire
Oct-29-21 08:47AM	Hedge Funds Are Piling Into Cerus Corporation (CERS) Insider Monkey
Oct-26-21 03:02PM	Analysts Estimate Cerus (CERS) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-19-21 08:00AM	Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021 Business Wire +5.25%
Oct-18-21 12:26PM	Cathie Woods Top 15 Small-Cap Stock Picks Insider Monkey
Oct-07-21 06:49AM	Investors in Cerus (NASDAQ:CERS) have made a return of 10% over the past five years Simply Wall St.
Oct-01-21 08:00AM	Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply Business Wire
Sep-20-21 08:00AM	Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021 Business Wire
Sep-15-21 08:00AM	Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference Business Wire
Aug-15-21 01:26PM	Billionaire Ray Dalio Bets on These 3 Strong Buy Stocks TipRanks
Aug-10-21 08:30AM	Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products Business Wire
Aug-04-21 08:30AM	Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors Business Wire +20.66%
05:01AM	Cerus Corporation (CERS) Q2 2021 Earnings Call Transcript Motley Fool
02:48AM	What Type Of Shareholders Make Up Cerus Corporation's (NASDAQ:CERS) Share Registry? Simply Wall St.
Aug-03-21 05:15PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:00PM	Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance Business Wire
06:30AM	Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex Business Wire
Jul-27-21 03:02PM	Earnings Preview: Cerus (CERS) Q2 Earnings Expected to Decline Zacks
Jul-20-21 08:30AM	Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021 Business Wire
Jul-14-21 08:30AM	Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets Business Wire
Jun-30-21 08:30AM	Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT® Fibrinogen Complex Business Wire
Jun-14-21 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2021 Business Wire
Jun-05-21 04:16AM	Cerus (NASDAQ:CERS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
May-17-21 09:00AM	Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets Business Wire
May-05-21 09:30AM	Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript Motley Fool +7.50%
May-04-21 05:35PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance Business Wire
02:30PM	Cerus Corp. to Host Earnings Call ACCESSWIRE
Apr-20-21 08:30AM	Cerus Corporation to Release First Quarter 2021 Financial Results on May 4, 2021 Business Wire
Apr-06-21 02:46AM	Introducing Cerus (NASDAQ:CERS), A Stock That Climbed 22% In The Last Year Simply Wall St.
Mar-03-21 08:30AM	Cerus Corporation to Participate in Jefferies Virtual Global Plasma Summit Business Wire
Feb-26-21 10:01AM	Cerus Corporation (CERS) Q4 2020 Earnings Call Transcript Motley Fool
Feb-25-21 04:01PM	Cerus Corporation Announces Record Fourth Quarter and Full Year 2020 Financial Results Business Wire
02:30PM	Cerus Corp. to Host Earnings Call ACCESSWIRE
Feb-24-21 05:00PM	Cerus Corporation and Shandong Zhongbaokang Medical Implements Partner to Establish Joint Venture in China Business Wire
10:14AM	A Preview Of Cerus's Earnings Benzinga
Feb-11-21 08:30AM	Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 Business Wire
Feb-05-21 01:39AM	Do Institutions Own Cerus Corporation (NASDAQ:CERS) Shares? Simply Wall St.
Feb-04-21 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Jan-23-21 11:30PM	Money Supply Is Up 26%, Inflation Coming? Cathie Woods Bitcoin Comments and Stock Picks Insider Monkey
Jan-11-21 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product Revenue Business Wire
Dec-15-20 08:30AM	Cerus Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets Business Wire
Dec-11-20 10:55PM	Is CERS A Good Stock To Buy Now? Insider Monkey
Dec-07-20 12:11AM	Cerus (NASDAQ:CERS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Dec-04-20 07:00PM	Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting Business Wire
Nov-30-20 12:00PM	Cerus (CERS) Is Up 2.47% in One Week: What You Should Know Zacks
08:30AM	Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation Business Wire
Nov-20-20 12:00PM	All You Need to Know About Cerus (CERS) Rating Upgrade to Buy Zacks
Nov-12-20 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Nov-01-20 07:59AM	Cerus Corporation (NASDAQ:CERS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Oct-30-20 03:30PM	Cerus Corporation (CERS) Q3 2020 Earnings Call Transcript Motley Fool -5.49%
Oct-29-20 06:05PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:02PM	Cerus Corporation Announces Record Third Quarter 2020 Results Business Wire
02:30PM	Cerus Corp.to Host Earnings Call ACCESSWIRE
Oct-28-20 10:13AM	Earnings Outlook for Cerus Benzinga -6.88%
Oct-22-20 12:34PM	Cerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
07:44AM	Is Cerus' (NASDAQ:CERS) 120% Share Price Increase Well Justified? Simply Wall St.
Oct-19-20 08:30AM	Cerus Corporation to Release Third Quarter 2020 Financial Results on October 29, 2020 Business Wire
Oct-13-20 08:30AM	Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Blood Business Wire
Sep-28-20 08:30AM	Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual Meeting Business Wire
Sep-16-20 07:49AM	Key Things To Understand About Cerus' (NASDAQ:CERS) CEO Pay Cheque Simply Wall St.
Sep-09-20 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire +5.28%
Aug-26-20 01:08PM	The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS Zacks
Aug-25-20 08:38AM	The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout Benzinga -7.54%
Aug-12-20 09:26AM	Did Hedge Funds Make The Right Call On Cerus Corporation (CERS) ? Insider Monkey
Aug-11-20 06:48AM	Have Insiders Been Buying Cerus Corporation (NASDAQ:CERS) Shares This Year? Simply Wall St.
Aug-07-20 08:30AM	Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch Business Wire
Aug-05-20 02:01AM	Cerus Corporation (CERS) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 05:15PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:02PM	Cerus Corporation Announces Record Second Quarter 2020 Results Business Wire
Jul-30-20 08:30AM	Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems Business Wire
Jul-28-20 12:33PM	Cerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-23-20 08:30AM	Cerus Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020 Business Wire
Jul-07-20 08:30AM	Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma Business Wire
Jul-06-20 10:01AM	What Kind Of Shareholders Hold The Majority In Cerus Corporation's (NASDAQ:CERS) Shares? Simply Wall St.
Jun-24-20 03:17PM	Cerus Corporation (CERS): Hedge Funds Getting Bullish Insider Monkey
Jun-17-20 11:30AM	Is Cerus (CERS) Outperforming Other Medical Stocks This Year? Zacks
Jun-15-20 05:43PM	Edited Transcript of CERS.OQ earnings conference call or presentation 5-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-12-20 08:30AM	Cerus Corporation Celebrates World Blood Donor Day Business Wire +7.86%
Jun-11-20 09:39AM	Cerus Shows Potential for Further Gains but Limit Your Risk TheStreet.com -15.92%
May-27-20 12:00PM	Cerus (CERS) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-26-20 08:30AM	Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex Business Wire
May-07-20 12:15PM	Cerus Corporation (NASDAQ:CERS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
May-06-20 07:33AM	Cerus Corporation (CERS) Q1 2020 Earnings Call Transcript Motley Fool
May-05-20 06:45PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	Cerus Corporation Announces First Quarter 2020 Results Business Wire
May-04-20 08:30AM	Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits Business Wire -7.47%
Apr-29-20 10:05AM	Moving Average Crossover Alert: Cerus Zacks
Apr-28-20 12:34PM	Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-24-20 08:30AM	Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020 Business Wire +5.50%
Apr-23-20 11:43AM	Cerus Corporation (CERS) Shares March Higher, Can It Continue? Zacks

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHULZE GAIL	Director	Nov 09	Option Exercise	2.86	25,000	71,500	53,116	Nov 09 08:43 PM
SCHULZE GAIL	Director	Nov 09	Sale	7.54	25,000	188,430	28,116	Nov 09 08:43 PM
Moore Carol	SVP Reg. & Quality	Nov 05	Option Exercise	3.75	110,000	412,500	289,555	Nov 09 08:38 PM
Moore Carol	SVP Reg. & Quality	Nov 05	Sale	7.94	110,000	873,191	181,276	Nov 09 08:38 PM
Benjamin Richard J	Chief Medical Officer	Nov 03	Option Exercise	4.56	165,000	753,133	176,035	Nov 05 07:41 PM
Green Kevin Dennis	Chief Financial Officer	Nov 03	Option Exercise	3.75	95,000	356,250	248,740	Nov 05 07:47 PM
Menard Chrystal	Chief Legal Officer	Nov 03	Sale	7.70	40,000	308,000	67,038	Nov 05 07:51 PM
Green Kevin Dennis	Chief Financial Officer	Nov 03	Sale	7.00	95,741	670,187	152,999	Nov 05 07:47 PM
Benjamin Richard J	Chief Medical Officer	Nov 03	Sale	7.68	165,000	1,267,750	76,035	Nov 05 07:41 PM
Swisher Daniel N JR	Director	Aug 04	Option Exercise	2.86	12,877	36,828	106,231	Aug 05 05:08 PM
Swisher Daniel N JR	Director	Aug 04	Sale	6.25	12,877	80,481	93,354	Aug 05 05:08 PM
Greenman William Mariner	President and CEO	Aug 03	Option Exercise	2.08	100,000	208,000	1,518,672	Aug 05 05:12 PM
Swisher Daniel N JR	Director	May 18	Option Exercise	2.90	5,000	14,500	64,868	May 20 07:21 PM
Swisher Daniel N JR	Director	May 18	Sale	5.75	5,000	28,735	59,868	May 20 07:21 PM
CORASH LAURENCE M	Chief Scientific Officer	Apr 30	Option Exercise	3.66	25,200	92,232	1,982,586	May 04 09:12 PM
Greenman William Mariner	President and CEO	Apr 16	Option Exercise	2.70	550,000	1,485,000	1,652,531	Apr 20 09:15 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 15	Sale	6.38	37,149	236,925	148,332	Mar 16 07:43 PM
Green Kevin Dennis	Chief Financial Officer	Mar 15	Sale	6.38	29,331	187,064	109,745	Mar 16 07:39 PM
Greenman William Mariner	President and CEO	Mar 15	Sale	6.38	156,407	997,517	975,257	Mar 16 07:37 PM
CORASH LAURENCE M	Chief Scientific Officer	Mar 15	Sale	6.38	23,775	151,630	1,942,605	Mar 16 07:34 PM
Benjamin Richard J	Chief Medical Officer	Mar 15	Sale	6.36	49,331	313,844	52,040	Mar 16 07:32 PM
Menard Chrystal	Chief Legal Officer	Mar 15	Sale	6.38	29,331	187,064	61,858	Mar 16 07:29 PM
Moore Carol	SVP Reg. & Quality	Mar 15	Sale	6.38	29,331	187,064	135,560	Mar 16 07:25 PM
Swisher Daniel N JR	Director	Feb 16	Option Exercise	2.90	10,000	29,000	69,868	Feb 18 06:46 PM
Swisher Daniel N JR	Director	Feb 16	Sale	7.78	10,000	77,797	59,868	Feb 18 06:46 PM
Menard Chrystal	Chief Legal Officer	Feb 08	Option Exercise	4.33	8,125	35,142	52,752	Feb 11 05:59 PM
Menard Chrystal	Chief Legal Officer	Feb 08	Sale	8.00	8,125	65,000	48,585	Feb 11 05:59 PM
ANDERSON TIMOTHY B	Director	Dec 22	Option Exercise	5.40	30,000	162,000	240,101	Dec 28 05:39 PM
Menard Chrystal	Chief Legal Officer	Dec 22	Option Exercise	4.37	211,327	923,379	134,001	Dec 28 05:43 PM
Jayaraman Vivek K	Chief Operating Officer	Dec 22	Option Exercise	4.32	56,105	242,400	188,440	Dec 28 05:44 PM
Jayaraman Vivek K	Chief Operating Officer	Dec 22	Sale	8.00	56,105	448,840	135,003	Dec 28 05:44 PM
Menard Chrystal	Chief Legal Officer	Dec 22	Sale	8.00	211,327	1,690,616	48,585	Dec 28 05:43 PM
ANDERSON TIMOTHY B	Director	Dec 22	Sale	8.31	39,336	326,856	200,765	Dec 28 05:39 PM
SCHULZE GAIL	Director	Dec 14	Option Exercise	2.48	15,000	37,200	62,393	Dec 15 08:51 PM
SCHULZE GAIL	Director	Dec 14	Sale	7.32	62,393	456,817	0	Dec 15 08:51 PM
Jayaraman Vivek K	Chief Commercial Officer	Dec 11	Option Exercise	4.33	18,895	81,815	178,898	Dec 15 08:44 PM
Menard Chrystal	Chief Legal Officer	Dec 11	Option Exercise	4.43	41,363	183,383	70,460	Dec 15 08:49 PM
Menard Chrystal	Chief Legal Officer	Dec 11	Sale	8.00	41,363	330,904	48,585	Dec 15 08:49 PM
Jayaraman Vivek K	Chief Commercial Officer	Dec 11	Sale	8.00	43,895	351,160	135,003	Dec 15 08:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience